Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety, tolerability, pharmacokinetics, and antitumor activity of ADCT-901 in participants with selected advanced solid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ADCT-901

Snippet

Sponsor: ADC Therapeutics S.A. | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED